Ira Duarte
Financieel Directeur/CFO bij HERON THERAPEUTICS, INC.
Vermogen: 528 959 $ op 31-05-2024
Oorsprong van het eerstegraads netwerk van Ira Duarte
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 18 | |
| Public Company | Agricultural Commodities/Milling | 16 | |
| Public Company | Biotechnology | 15 | |
| Subsidiary | Pharmaceuticals: Major | 13 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ira Duarte via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | Pharmaceuticals: Major | Director/Board Member General Counsel Chief Tech/Sci/R&D Officer Director/Board Member | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Chairman Director/Board Member Corporate Officer/Principal | |
| University of Copenhagen | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Graduate Degree | |
| SALIX PHARMACEUTICALS, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Arbor Pharmaceuticals LLC
 Arbor Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Arbor Pharmaceuticals LLC develops pharmaceutical products, which focuses on cardiovascular, hospital and pediatric markets. It offers edarbyclor, cetylev, horizant, zenzedi, evekeo, sklice, and eryhromycin. The company was founded by Jarrett T. Disbrow and Edward J. Schutter and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Founder Corporate Officer/Principal Chairman | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal Director/Board Member Director/Board Member | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Vitruvias Therapeutics, Inc.
 Vitruvias Therapeutics, Inc. Medical/Nursing ServicesHealth Services Vitruvias Therapeutics LLC researches and develops generic drugs. The company was founded by Carl L. Whatley and Bryce Harvey and is headquartered in Auburn, AL. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree | |
Avenge Bio, Inc.
 Avenge Bio, Inc. Pharmaceuticals: MajorHealth Technology Avenge Bio, Inc. is an oncology-focused biotechnology company based in the United States. The American company develops cell-based immunotherapeutic products for the treatment of solid tumors using its proprietary Lococyte™ platform. The platform delivers engineered cells to the local tumor environment, generating high concentrations of immune effector molecules in proximity to the tumor, which initiates a robust, local, and durable systemic immune response while avoiding toxicities associated with systemic immunotherapies. Avenge's most advanced product candidate, AVB-001, produces native IL-2 immunotherapy and is initially being studied in metastatic peritoneal cancers such as ovarian cancer. The company has additional pipeline candidates for the treatment of a wide range of cancers, including pancreatic, lung, and breast cancers. Avenge was founded in 2019 by Paul Kevin Wotton and Michael Thomas Heffernan, with Heffernan serving as CEO since incorporation. | Pharmaceuticals: Major | Founder Founder | |
Broadfin Capital LLC
 Broadfin Capital LLC Investment ManagersFinance Broadfin Capital LLC (Broadfin) is an independent hedge fund manager headquartered in New York City. The firm was founded by Kevin Kotler in 2005. Through the funds they advise, the firm may provide investment management services to individuals, investment companies, pooled investment vehicles, pension and profit sharing plans, trusts, estates, governmental plans, endowments, foundations, charitable organizations, corporations, insurance companies, limited partnerships, commingled investment trusts, and other entities. | Investment Managers | Chief Executive Officer Analyst-Equity | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| OCATA THERAPEUTICS INC | Pharmaceuticals: Major | Chief Executive Officer Chairman | |
| University of Pennsylvania | College/University | Graduate Degree Undergraduate Degree | |
Vensun Pharmaceuticals, Inc.
 Vensun Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vensun Pharmaceuticals, Inc. engages in the development, manufacture, and supply of generic prescription drugs. It offers Crisoprodol tablets, Clopidogrel tablets, Donepezil Hydrochloride, Fluoxetine Capsules, Nystatin Topical powder, and Pramipexole Dihydrochloride tablets. The company was founded in July 2011 and is headquartered in Yardley, PA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Defender Pharmaceuticals, Inc. | Chief Executive Officer Chief Executive Officer | ||
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| University of Kentucky | College/University | Doctorate Degree Undergraduate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree | |
AlloCure, Inc.
 AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| FLEXION THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel | |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Abzu ApS
 Abzu ApS Packaged SoftwareTechnology Services Abzu ApS provides technology services. It offers Abzu AI platform. The firm specializes in data, deep and machine learning, AI platform, cell based model, predictive problems and artificial general intelligence. The company was founded by Casper Skern Wilstrup in January 2018 and is headquartered in Copenhagen, Denmark. | Packaged Software | Director/Board Member | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DYSIS Medical Ltd.
 DYSIS Medical Ltd. Medical SpecialtiesHealth Technology DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom. | Medical Specialties | Director/Board Member | |
C.W. Obel A/S
 C.W. Obel A/S Financial ConglomeratesFinance C.W. Obel A/S provides investment services to industrial companies. The firm's financial assets are located in collaboration with independent financial advisor used by banks and pension companies. The company was founded by Christen Winther Obel in 1787 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member | |
| ABIONYX PHARMA | Pharmaceuticals: Major | General Counsel | |
| LEXEO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| Western Michigan University | College/University | Masters Business Admin | |
| Purdue University | College/University | Undergraduate Degree | |
| RANI THERAPEUTICS HOLDINGS, INC. | Biotechnology | General Counsel | |
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Biotechnology | Chief Executive Officer | |
| RECEPTOS INC | Pharmaceuticals: Major | General Counsel | |
Forcepoint LLC
 Forcepoint LLC Packaged SoftwareTechnology Services Forcepoint LLC provides unified web, email, and data security solutions. It offers data security consulting, security intelligence consulting, cyber security intelligence, training and technical certification, implementation packages, and government certification services. The company was founded in 1994 and is headquartered in Austin, TX. | Packaged Software | General Counsel | |
JW Asset Management LLC /Private Equity/
 JW Asset Management LLC /Private Equity/ Investment ManagersFinance JW Asset Management LLC (JW Asset Management) is a private equity subsidiary of JW Asset Management LLC founded in 2003 by Jason Wild. The firm is headquartered in Armonk, New York. | Investment Managers | President | |
| University of Wisconsin | College/University | Undergraduate Degree | |
Entourage Effect Capital LLC
 Entourage Effect Capital LLC Investment ManagersFinance Entourage Effect Capital LLC (Entourage Effect Capital) a venture capital firm founded by Matthew Hawkins, Andy Sturner & Dov Szapiro in 2015. The firm is headquartered in Irving, Dallas. | Investment Managers | Consultant / Advisor | |
| NETA NJ LLC | Director/Board Member | ||
JW Asset Management LLC
 JW Asset Management LLC Investment ManagersFinance JW Asset Management LLC (JW Asset) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Armonk, New York. The firm was founded by Jason Wild in 2003. JW Asset provides discretionary investment management services to certain private funds. | Investment Managers | Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 44 |
| Denemarken | 6 |
| Verenigd Koninkrijk | 2 |
| Frankrijk | 2 |
Sectoraal
| Health Technology | 31 |
| Consumer Services | 10 |
| Finance | 6 |
| Technology Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 171 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 62 |
| President | 47 |
| Chief Executive Officer | 46 |
Sterkste connecties
| Insiders | |
|---|---|
| Mette Agger | 30 |
| Paul Wotton | 27 |
| Thomas Dyrberg | 24 |
| Edward Schutter | 24 |
| James McNulty | 23 |
| Michael Heffernan | 23 |
| Robert Radie | 18 |
| Craig Collard | 18 |
| George Ng | 17 |
| Craig Johnson | 17 |
| David Szekeres | 15 |
| Adam Morgan | 15 |
| Kevin Kotler | 14 |
| Charles Bramlage | 13 |
| Alastair Stuart McEwan | 12 |
- Beurs
- Insiders
- Ira Duarte
- Bedrijfsconnecties
